HomeNewsIndiaCOVID-19 impact: Plan afoot to make cities cycle friendly, registration for India Cycles4Change Challenge opens

COVID-19 impact: Plan afoot to make cities cycle friendly, registration for India Cycles4Change Challenge opens

Eleven cities to be shortlisted under the initiative open to cities Eligible cities can register and submit applications on the portal from July 10 to 21.

July 10, 2020 / 22:40 IST
Story continues below Advertisement

To support Indian cities to quickly implement cycling-friendly initiatives in response to COVID-19, the Ministry of Housing and Urban Affairs along with Smart Cities Mission and The Institute for Transportation and Development Policy (ITDP) opened registration for India Cycles4Change Challenge on July 10.

The challenge is open to all cities under the Smart Cities Mission, capital cities of states/union territories and all cities with more than 5 lakh population. Eligible cities can register and submit their applications on the portal from July 10 to 21.

Story continues below Advertisement

The challenge was launched on June 25, 2020, by Minister of Housing and Urban Affairs Hardeep Singh Puri.

The cities can register for the India Cycles4Change Challenge on the portal at https://smartnet.niua.org/indiacyclechallenge/.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show